Skip to main content
A scary good deal on trusted journalism
Get full digital access to globeandmail.com
$0.99
per week for 24 weeks SAVE OVER $140
OFFER ENDS OCTOBER 31
A scary good deal on trusted journalism
$0.99
per week
for 24 weeks
SAVE OVER $140
OFFER ENDS OCTOBER 31
// //

Anderson Silva waits for the start of a middleweight fight against Nick Diaz during UFC 183 at the MGM Grand Garden Arena on January 31, 2015 in Las Vegas, Nevada.

Steve Marcus/Getty Images

Former UFC middleweight champion Anderson Silva has tested positive for steroid use.

Silva, the 39-year-old Brazilian widely considered the greatest mixed martial artist in the young sport's history, tested positive for Drostanolone metabolites and another steroid in an out-of-competition test Jan. 9.

Nick Diaz, his opponent at UFC 183 last Saturday, also tested positive for elevated levels of marijuana metabolites in results released Tuesday night by the Nevada Athletic Commission.

Story continues below advertisement

The UFC said the commission is doing further testing to confirm the results, but the stunning announcement casts a large shadow over Silva's impressive comeback from a badly broken leg last Saturday for a unanimous-decision victory over Diaz.

In a brief statement, the UFC said it was "disappointed to learn of these initial results."

"Anderson Silva has been an amazing champion and a true ambassador of the sport of mixed martial arts and the UFC, in Brazil as well as around the world," the UFC's statement added. "The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by its athletes."

Silva (34-6) beat Diaz by a wide decision last weekend in Las Vegas, winning every round on two of the three judges' scorecards. The fight was a triumphant return to the cage for Silva, who broke his lower left leg 13 months ago.

UFC President Dana White is among those who have proclaimed Silva to be the sport's greatest fighter. He won 10 consecutive title defences over seven years as the UFC's 185-pound champion, most of them showcasing his incredible athleticism and striking skills, until losing the belt to Chris Weidman in July 2013 and breaking his leg in their rematch.

Yahoo Sports first reported Silva's failed test and Diaz's latest failed marijuana test. Silva and Diaz will face a disciplinary hearing before the Nevada commission on Feb. 17, and their licenses to fight likely will be suspended.

Silva has never publicly failed a drug test in his MMA career, but could face a nine-month suspension for a first offence.

Story continues below advertisement

Diaz tested positive for marijuana use twice already in his career, in 2007 and 2012, and could face a lengthy suspension. He returned from a self-imposed 22-month absence to take on Silva for a lucrative payday.

In another statement, the UFC said it will "fully respect" the Nevada commission's suspension decision, noting that Diaz has violated the UFC's fighter conduct policy and his promotional agreement.

Silva's manager, Ed Soares, didn't immediately return a request for comment.

Immediately after his victory last weekend, Silva said he hadn't decided whether to retire from the sport. He planned to consult with his wife and five children before determining his future.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies